Cover Image

<sup>64</sup>Cu-DOTHA<sub>2</sub>-PSMA, a Novel PSMA PET Radiotracer for Prostate Cancer with a Long Imaging Time Window

Prostate cancer imaging and late-stage management can be improved with prostate-specific membrane antigen (PSMA)-targeting radiotracers. We developed a PSMA positron emission tomography (PET) radiotracer, DOTHA<sub>2</sub>-PSMA radiolabeled with <sup>64</sup>Cu (T<sub>1...

Full description

Saved in:

Bibliographic Details
Main Authors:	Marie-Christine Milot (Author), Ophélie Bélissant Benesty (Author), Véronique Dumulon-Perreault (Author), Samia Ait-Mohand (Author), Patrick O. Richard (Author), Étienne Rousseau (Author), Brigitte Guérin (Author)
Format:	Book
Published:	MDPI AG, 2022-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Different PSMA Radiopharmaceuticals: A Comparative Study of [<sup>18</sup>F]F-PSMA-1007, [<sup>18</sup>F]F-JK-PSMA-7, and [<sup>99m</sup>Tc]Tc-PSMA-I&S in the Skeletal System
by: Zsófia Sára Mikó, et al.
Published: (2024)

Advances in <sup>177</sup>Lu-PSMA and <sup>225</sup>Ac-PSMA Radionuclide Therapy for Metastatic Castration-Resistant Prostate Cancer
by: Sui Wai Ling, et al.
Published: (2022)

Efficacy and Safety of [<sup>225</sup>Ac]Ac-PSMA-617 Augmented [<sup>177</sup>Lu]Lu-PSMA-617 Radioligand Therapy in Patients with Highly Advanced mCRPC with Poor Prognosis
by: Florian Rosar, et al.
Published: (2021)

Development and Validation of Analytical Methods for Radiochemical Purity of <sup>177</sup>Lu-PSMA-1
by: Pauline Orhon, et al.
Published: (2022)

Hematological Toxicity in Mice after High Activity Injections of <sup>177</sup>Lu-PSMA-617
by: Amanda Kristiansson, et al.
Published: (2022)

A Preclinical Study of an <sup>125</sup>I-Labeled PSMA Ligand for Prostate-Cancer Puncture
by: Xiaohui Luan, et al.
Published: (2022)

[<sup>177</sup>Lu]Lu-PSMA-617 (Pluvicto<sup>TM</sup>): The First FDA-Approved Radiotherapeutical for Treatment of Prostate Cancer
by: Ute Hennrich, et al.
Published: (2022)

Differences in Distribution and Detection Rate of the [<sup>68</sup>Ga]Ga-PSMA Ligands PSMA-617, -I&T and -11-Inter-Individual Comparison in Patients with Biochemical Relapse of Prostate Cancer
by: Falk Gühne, et al.
Published: (2021)

Heterodimeric Radiotracer Targeting PSMA and GRPR for Imaging of Prostate Cancer-Optimization of the Affinity towards PSMA by Linker Modification in Murine Model
by: Fanny Lundmark, et al.
Published: (2020)

[<sup>68</sup>Ga]Ga-PSMA-11: The First FDA-Approved <sup>68</sup>Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer
by: Ute Hennrich, et al.
Published: (2021)

Optimized <sup>68</sup>Ga-Labeled Urea-Based PSMA-Targeted PET Tracers for Prostate Cancer
by: Yitian Wu, et al.
Published: (2022)

[<sup>18</sup>F]F-PSMA-1007 Radiolabelling without an On-Site Cyclotron: A Quality Issue
by: Valentina Di Iorio, et al.
Published: (2021)

Sublingual Atropine Administration as a Tool to Decrease Salivary Glands' PSMA-Ligand Uptake: A Preclinical Proof of Concept Study Using [<sup>68</sup>Ga]Ga-PSMA-11
by: Vincent Nail, et al.
Published: (2022)

Optimized Therapeutic <sup>177</sup>Lu-Labeled PSMA-Targeted Ligands with Improved Pharmacokinetic Characteristics for Prostate Cancer
by: Yitian Wu, et al.
Published: (2022)

Characterization of Non-Specific Uptake and Retention Mechanisms of [<sup>177</sup>Lu]Lu-PSMA-617 in the Salivary Glands
by: Nathalie Heynickx, et al.
Published: (2023)

[<sup>177</sup>Lu]Lu-PSMA-617 Salivary Gland Uptake Characterized by Quantitative <i>In Vitro</i> Autoradiography
by: Roswitha Tönnesmann, et al.
Published: (2019)

Imageological/Structural Study regarding the Improved Pharmacokinetics by <sup>68</sup>Ga-Labeled PEGylated PSMA Multimer in Prostate Cancer
by: Huihui Zhang, et al.
Published: (2023)

Optimization of Automated Radiosynthesis of Gallium-68-Labeled PSMA11 with Two [<sup>68</sup>Ge]Ge/[<sup>68</sup>Ga]Ga Generators: Fractional Elution or Prepurification?
by: Flore Durieux, et al.
Published: (2023)

Development of [<sup>225</sup>Ac]Ac-PSMA-I&T for Targeted Alpha Therapy According to GMP Guidelines for Treatment of mCRPC
by: Eline L. Hooijman, et al.
Published: (2021)

Initial Experience of Clinical Use of [<sup>99m</sup>Tc]Tc-PSMA-T4 in Patients with Prostate Cancer. A Pilot Study
by: Jarosław B. Ćwikła, et al.
Published: (2021)

Competition ('Steal' Phenomenon) between [<sup>68</sup>Ga]Ga-PSMA-11 Uptake in Prostate Tumor Tissue Versus Healthy Tissue
by: Esmée C. A. van der Sar, et al.
Published: (2021)

Standardization of the [<sup>68</sup>Ga]Ga-PSMA-11 Radiolabeling Protocol in an Automatic Synthesis Module: Assessments for PET Imaging of Prostate Cancer
by: Leonardo L. Fuscaldi, et al.
Published: (2021)

A DFT Study on the Kinetics of HOO<sup>•</sup>, CH<sub>3</sub>OO<sup>•</sup>, and O<sub>2</sub><sup>•−</sup> Scavenging by Quercetin and Flavonoid Catecholic Metabolites
by: Ana Amić, et al.
Published: (2023)

RadioLigand Therapy with [<sup>177</sup>Lu]Lu-PSMA-617 for Salivary Gland Cancers: Literature Review and First Compassionate Use in France
by: Marie Terroir, et al.
Published: (2023)

Reviewing the Bio-Applications of SrAl<sub>2</sub>O<sub>4</sub>:Eu<sup>2+</sup>, Dy<sup>3+</sup> Phosphor
by: Maryam Mollazadeh-Bajestani, et al.
Published: (2023)

Improving Overall Survival and Quality of Life in Patients with Prostate Cancer and Neuroendocrine Tumors Using <sup>177</sup>Lu-iPSMA and <sup>177</sup>Lu-DOTATOC: Experience after 905 Treatment Doses
by: Myrna Luna-Gutiérrez, et al.
Published: (2023)

Late Na<sup>+</sup> Current Is [Ca<sup>2+</sup>]<sub>i</sub>-Dependent in Canine Ventricular Myocytes
by: Dénes Kiss, et al.
Published: (2021)

H<sub>2</sub>O<sub>2</sub>/Ca<sup>2+</sup>/Zn<sup>2+</sup> Complex Can Be Considered a "Collaborative Sensor" of the Mitochondrial Capacity?
by: Ester Sara Di Filippo, et al.
Published: (2022)

Current Status of PSMA-Radiotracers for Prostate Cancer: Data Analysis of Prospective Trials Listed on ClinicalTrials.gov
by: Claus Zippel, et al.
Published: (2020)

Understanding the Physiological Role of Electroneutral Na<sup>+</sup>-Coupled HCO<sub>3</sub><sup>−</sup> Cotransporter and Its Therapeutic Implications
by: Jingjing Wang, et al.
Published: (2022)

Trace Metal Impurities Effects on the Formation of [<sup>64</sup>Cu]Cu-diacetyl-bis(<i>N</i><sup>4</sup>-methylthiosemicarbazone) ([<sup>64</sup>Cu]Cu-ATSM)
by: Mitsuhiro Shinada, et al.
Published: (2023)

Rare-Earth-Metal (Nd<sup>3+</sup>, Ce<sup>3+</sup> and Gd<sup>3+</sup>)-Doped CaF<sub>2</sub>: Nanoparticles for Multimodal Imaging in Biomedical Applications
by: Zhenfeng Yu, et al.
Published: (2022)

Radionuclide Cisternography with [<sup>64</sup>Cu]Cu-DOTA
by: Julia Greiser, et al.
Published: (2023)

Comparative Evaluation of Radiochemical and Biological Properties of <sup>131</sup>I- and [<sup>99m</sup>Tc]Tc(CO)<sub>3</sub>-Labeled RGD Analogues Planned to Interact with the α<sub>v</sub>β<sub>3</sub> Integrin Expressed in Glioblastoma
by: Danielle V. Sobral, et al.
Published: (2022)

[<sup>111</sup>In]In/[<sup>177</sup>Lu]Lu-AAZTA<sup>5</sup>-LM4 SST<sub>2</sub>R-Antagonists in Cancer Theranostics: From Preclinical Testing to First Patient Results
by: Berthold A. Nock, et al.
Published: (2023)

Development of a Promising <sup>18</sup>F-Radiotracer for PET Imaging Legumain Activity In Vivo
by: Chunmei Lu, et al.
Published: (2022)

Covalent <sup>18</sup>F-Radiotracers for SNAPTag: A New Toolbox for Reporter Gene Imaging
by: Sophie Stotz, et al.
Published: (2021)

H<sub>2</sub>O<sub>2</sub> and Ca<sup>2+</sup> Signaling Crosstalk Counteracts ABA to Induce Seed Germination
by: Mengjie Cheng, et al.
Published: (2022)

Synthesis and Evaluation of the Cytotoxic Activity of Water-Soluble Cationic Organometallic Complexes of the Type [Pt(η<sup>1</sup>-C<sub>2</sub>H<sub>4</sub>OMe)(L)(Phen)]<sup>+</sup> (L = NH<sub>3</sub>, DMSO; Phen = 1,10-Phenanthroline)
by: Federica De Castro, et al.
Published: (2021)

H<sub>2</sub>O<sub>2</sub>-PLA-(Alg)<sub>2</sub>Ca Hydrogel Enriched in Matrigel<sup>®</sup> Promotes Diabetic Wound Healing
by: Alexandra Cătălina Bîrcă, et al.
Published: (2023)